OPKO Health Buys Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


OPKO Health, Inc. (NYSE: OPK) has entered into a definitive agreement toacquire Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos eCosmeticos Ltda. Domiciled in Sao Paulo, Brazil, Silcon expands OPKO'spresence in Latin America and complements business activities of units inChile and Mexico.Silcon broadens OPKO's reach in Latin America with this entry into the largestmarket in the region. Beyond providing important cross marketing opportunitiesfor its growing portfolio of products, Silcon represents an importantstrategic element for OPKO's diagnostic business; it permits commercializationof the 4KScore™ prostate cancer test in Brazil as a reference laboratory testwhile OPKO obtains local approval to market its point of care microfluidicsdisposable test cassettes.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsM&A